Lifitegrast Ophthalmic Solution 5.0% for Treatment of Dry Eye Disease: Overview of Clinical Trial Program

scientific article published on 01 January 2019

Lifitegrast Ophthalmic Solution 5.0% for Treatment of Dry Eye Disease: Overview of Clinical Trial Program is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.18433/JPPS29895
P698PubMed publication ID30636670

P2093author name stringClara C Chan
C Lisa Prokopich
P433issue1
P921main subjecteye diseaseQ3041498
P304page(s)49-56
P577publication date2019-01-01
P1433published inJournal of Pharmacy and Pharmaceutical SciencesQ15760233
P1476titleLifitegrast Ophthalmic Solution 5.0% for Treatment of Dry Eye Disease: Overview of Clinical Trial Program
P478volume22

Search more.